Blood test may let some throat cancer patients skip radiation after surgery

NCT ID NCT07513389

First seen Jun 25, 2026 · Last updated Jul 01, 2026 · Updated 3 times

Summary

This study is for people with HPV-related throat cancer who have surgery to remove the tumor. Normally, some patients also get radiation afterward to lower the risk of cancer coming back. This trial tests whether it's safe to skip that radiation if a blood test two weeks after surgery shows no signs of cancer DNA. Participants will be closely monitored with regular check-ups and blood tests to catch any recurrence early. The goal is to see if avoiding radiation can reduce side effects without compromising cancer control.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
active surveillance with ctHPVDNA blood test (NavDx®)
What this could lead to
If successful, this could allow many patients to avoid the side effects of radiation after surgery, while still catching any recurrence early through a simple blood test.
What could go wrong
This is a small, early-phase trial with only 36 participants, so results may not apply to everyone. There is a risk that skipping radiation could lead to cancer returning in some patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HPV-ASSOCIATED OROPHARYNGEAL SQUAMOUS CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Medical University of South Carolina

    RECRUITING

    Charleston, South Carolina, 29425, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.